Use of the M3 protein of MHV68 to block binding of a...

Details Use of the M3 protein of MHV68 to block binding of a... Use of the M3 protein of MHV68 to block binding of a...

2005-01-18

2005-01-18

Spector, Lorraine (Department: 1646)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Amino acid sequence disclosed in whole or in part; or...

C530S826000, C530S350000, C435S375000, C435S007200, C435S007300, C436S501000, C424S193100, C424S229100

Reexamination Certificate

active

06843991

ABSTRACT:
A pharmaceutical composition comprises M3 protein as encoded by virus MHV 68, or a homologue of said M3 protein, for use in binding to a chemokine or a chemokine analogue in vivo, or to block binding of chemokines to corresponding cell surface receptors in vivo, to produce an immunomodulatory effect, or to bind to a chemokine analogue present in a virus or parasite to block its entry into cells.

REFERENCES:
patent: 5428130 (1995-06-01), Capon et al.
patent: WO 95 12673 (1995-05-01), None
patent: WO 97 44054 (1997-11-01), None
patent: WO 98 36766 (1998-08-01), None
patent: WO 0121204 (2001-03-01), None
van Berkel et al. J. Virol. 2000; 74:6741-6747.*
Parry et al. (Journal of Experimental Medicine (2000) 191(3): 573-578).*
U.S. provisional application No. 60/154,799, McFadden et al., filed Sep. 20, 1999.
Van Berkel, Victor et al., “Identification and initial characterization of the murine gammaherpesvirus 68 gene M3, encoding an abundantly secreted protein”,Journal of Virology, vol. 73, No. 5, May 1999, pp. 4524-4529.
Lalani, A.S. et al., “Modulating chemokines: more lessons from viruses”,Immunology Today, GB, Elseveier Publications, Cambridge, vol. 21, No. 2, Feb. 2000, pp. 100-106.
Guerico et al., “Binding of a peptide antigen of multiple HLA alleles allows definition of an A2-like supertype”,Journal of Immunology, 1995, 154, pp. 685-693.
Alcami and Smith, “Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity”,Journal of Virology, Aug. 1995, pp. 4633-4639.
Engeman et al., “Inhibition of functional T Cell priming and contact hypersensitivity responses by treatment with anti-secondary lymphoid chemokine antibody during Hapten sensitization”,Journal of Immunology, [2000] 164, pp. 5207-4214.
Tsung et al., “Gene expression and cytopathetic effect on vaccinia virus inactivated by psoralen and long-wave UV light”,Journal of Virology, [1996] 70, pp. 165-171.
Fauci, “Host factors and the pathogenesis of HIV-induced disease”,Nature, vol. 384, Dec. 12, 1995, pp. 529-534.
Horuk et al., “A receptor for the malarial parasitePlasmodium vivax: The erythrocyte chemokine receptor”,Science, vol. 1261, Aug. 24, 1993, pp. 1182-1184.
Parry et al., “A broad spectrum secreted chemokine binding protein encoded by herpesvirus”,Journal of Experimental Medicine, Feb. 7, 2000, vol. 191, No. 3, pp. 573-578.
Alcami and Smith, “A soluble receptor for interluekin-1β encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection”,Cell, 1992, 71, pp. 153-167.
Upton et al., “Encoding of a homolog of the IFN-gamma receptor by myxoma virus”,Science, 1992, 258, pp. 1369-1372.
Chastel et al., A herpesvirus from an Europian Schrew (Crodidura Russula),Acta Virologica, 1994, 38, p. 309.

Affiliated with

Also associated with

Rating

Use of the M3 protein of MHV68 to block binding of a... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of the M3 protein of MHV68 to block binding of a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of the M3 protein of MHV68 to block binding of a... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3388450